Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
CNS Neurosci Ther ; 24(2): 115-125, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29214729

RESUMEN

AIMS: Finasteride inhibits the conversion of testosterone to dihydrotestosterone. Because androgen regulates dopaminergic system in the brain, it could be hypothesized that finasteride may inhibit dopaminergic system. The present study therefore investigates the effects of finasteride in adolescent and early developmental rats on dopaminergic system, including contents of dopamine and its metabolites (dihydroxy phenyl acetic acid and homovanillic acid) and tyrosine hydroxylase expressions both at gene and protein levels. Meanwhile, open-field behaviors of the rats are examined because of the regulatory effect of dopaminergic system on the behaviors. METHODS: Open-field behaviors were evaluated by exploratory and motor behaviors. Dopamine and its metabolites were assayed by liquid chromatography-mass spectrometry. Tyrosine hydroxylase mRNA and protein expressions were determined by real-time qRT-PCR and western blot, respectively. RESULTS: It was found that in adolescent male rats, administration of finasteride at doses of 25 and 50 mg/kg for 14 days dose dependently inhibited open-field behaviors, reduced contents of dopamine and its metabolites in frontal cortex, hippocampus, caudate putamen, nucleus accumbens, and down-regulated tyrosine hydroxylase mRNA and protein expressions in substantia nigra and ventral tegmental area. However, there was no significant change of these parameters in early developmental rats after finasteride treatment. CONCLUSION: These results suggest that finasteride inhibits dopaminergic system and open-field behaviors in adolescent male rats by inhibiting the conversion of testosterone to dihydrotestosterone, and imply finasteride as a potential therapeutic option for neuropsychiatric disorders associated with hyperactivities of dopaminergic system and androgen.


Asunto(s)
Encéfalo/efectos de los fármacos , Dopaminérgicos/farmacología , Conducta Exploratoria/efectos de los fármacos , Finasterida/farmacología , Actividad Motora/efectos de los fármacos , Animales , Encéfalo/metabolismo , Dopamina/metabolismo , Relación Dosis-Respuesta a Droga , Conducta Exploratoria/fisiología , Masculino , Actividad Motora/fisiología , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas Wistar , Maduración Sexual , Tirosina 3-Monooxigenasa/metabolismo
2.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 27(6): 739-42, 2005 Dec.
Artículo en Zh | MEDLINE | ID: mdl-16447649

RESUMEN

OBJECTIVE: To study the effect of testosterone propionate (TP) on the distribution pattern of calcitonin gene-related peptide (CGRP) in two types of motoneuron (Mn) pools in rats. METHOD: The double labeling of cholera toxin B subunit coupled with colloidal gold (CB-Au) retrograde identification combining with immunocytochemistry was mainly used to reveal the distribution pattern of CGRP-like immunoreactivity (CGRP-LI) and its changes in the motoneuron pools labeled by CB-Au. RESULT: TP injected intramuscularly 28 days later significantly decreased CGRP expression in Mn pool innervating extensor digitorum longus (EDL, fast-twitch), comparing with corresponding control and castration group respectively (P < 0.001), while no significant effect on Mn pools innervating soleus (SOL, slow-twitch, P > 0.05) was observed. CONCLUSION: EDL-Mn pool is more sensitive to testosterone propionate than SOL-Mn pool in regulating CGRP expression.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/metabolismo , Neuronas Motoras/efectos de los fármacos , Fibras Musculares de Contracción Rápida/citología , Fibras Musculares de Contracción Lenta/citología , Propionato de Testosterona/farmacología , Animales , Péptido Relacionado con Gen de Calcitonina/efectos de los fármacos , Masculino , Neuronas Motoras/metabolismo , Fibras Musculares de Contracción Rápida/efectos de los fármacos , Fibras Musculares de Contracción Lenta/efectos de los fármacos , Ratas , Ratas Wistar
3.
Behav Brain Res ; 252: 388-95, 2013 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-23756138

RESUMEN

Aging is usually associated with a progressive disruption of the redox balance leading to recurrent damage resulting from oxidative stress. Oxidative stress resulting from excessive free-radical release is likely implicated in the initiation and progression of motor behavior disorders. Therefore, antioxidant therapies have received considerable attention in motor behavior defects treatment. The nuclear factor erythroid 2-related factor 2 (Nrf2) binds to antioxidant response element (ARE) to induce antioxidant and phase II detoxification enzymes under conditions of oxidative stress, which reduces oxidative stress and accumulation of toxic metabolites. Testosterone has many physiological and behavioral effects throughout the lifespan and shown to affect motor behavior in adult male rats and gonadectomized rats. However, whether Nrf2-ARE pathway is activated after testosterone administration has not been studied in aged rats. The tilting-plane test and the horizontal-wire test as well as the oxidative stress parameters, the expression of Nrf2, heme oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase-1 (NQO1) and the number of tyrosine hydroxylase immunoreactive (TH-ir) cells in brain were examined in aged rats following chronic subcutaneous injections of testosterone propionate (TP). Our study showed that chronic TP supplement significantly ameliorated the decline of balancing reactions and muscular strength associated with aging. Oxidative stress parameters were ameliorate, the expression of Nrf2, HO-1 and NQO1 at protein or gene levels and the number of TH-ir cells significantly increased in substantia nigra or caudate putamen after TP treatment in aged rats. Our findings demonstrated that chronic TP treatment activated Nrf2-ARE pathway may influence the maintenance of the balancing reactions and muscular strength and reduce TH-ir cells death in aged rats. Therefore, TP supplement have shown for therapeutic strategies in the treatment and modification of motor behavior disorders.


Asunto(s)
Envejecimiento/efectos de los fármacos , Andrógenos/administración & dosificación , Elementos de Respuesta Antioxidante , Encéfalo/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Transducción de Señal/efectos de los fármacos , Propionato de Testosterona/administración & dosificación , Factores de Edad , Animales , Antioxidantes/metabolismo , Encéfalo/metabolismo , Glutatión/metabolismo , Hemo-Oxigenasa 1/genética , Hemo-Oxigenasa 1/metabolismo , Masculino , Malondialdehído/metabolismo , NAD(P)H Deshidrogenasa (Quinona)/genética , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Factor 2 Relacionado con NF-E2/genética , Estrés Oxidativo/efectos de los fármacos , Equilibrio Postural/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Espectrofotometría , Estadísticas no Paramétricas
4.
Artículo en Zh | MEDLINE | ID: mdl-16408750

RESUMEN

OBJECTIVE: To understand what role of the transient outward potassium channels and the delayed rectifier potassium channels play in the mechanism of salicylate-induced tinnitus. METHODS: The effects of salicylate on the transient outward potassium channels and the delayed rectifier potassium channels in freshly dissociated inferior colliculus neurons of rats were studied, using the whole-cell voltage clamp method. RESULTS: Salicylate blocked the transient outward potassium current (I(K(A and the delayed rectifier potassium current (I(K(DR in concentration-dependent manner (0.1-1 mmol/L). The IC50 values for the blocking action of salicylate on I(K(A)) and I(K(DR)) were 2.27 and 0.80 mmol/L, respectively. At a concentration of 1 mmol/L, salicylate did not shift the activation and inactivation curves of I(K(A)), but significantly shifted the activation and inactivation curves of I(K(DR)) negatively by approximately 11 mV and 24 mV. CONCLUSIONS: Salicylate inhibits both I(K(A)) and I(K(DR)) in rat inferior colliculus neurons but only significantly affects the activation and inactivation kinetics of I(K(DR)). Effects of I(K(A)) and I(K(DR)), especially I(K(DR)), by salicylate may play an important role in salicylate-induced tinnitus.


Asunto(s)
Colículos Inferiores/efectos de los fármacos , Neuronas/efectos de los fármacos , Canales de Potasio/efectos de los fármacos , Salicilatos/farmacología , Animales , Canales de Potasio de Tipo Rectificador Tardío/efectos de los fármacos , Colículos Inferiores/citología , Masculino , Neuronas/fisiología , Técnicas de Placa-Clamp , Canales de Potasio/fisiología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA